Lululemon stock price target lowered to $200 by Goldman Sachs on weak outlook

Goldman Sachs has reduced its price target on Lululemon Athletica Inc. (LULU) to $200, citing Lululemon's downward revision of its FY25 outlook due to softening consumer demand across its key markets and significant margin pressures. These pressures include increased tariffs, changes to the de minimis exemption, and elevated promotional activity, collectively projected to create a ~$320 million EBIT headwind by FY26. This assessment aligns with other recent downgrades from firms like William Blair and Stifel, reflecting broader concerns about LULU's U.S. sales recovery and macroeconomic challenges in China, despite a recent Q2 EPS beat.

Analysis

Lululemon Athletica (LULU) is facing significant headwinds, evidenced by multiple analyst downgrades and a price target reduction from Goldman Sachs to $200.00. The negative sentiment is primarily driven by the company's own downward revision of its fiscal year 2025 outlook, citing softening consumer demand in the US, Canada, and China. This outlook is compounded by severe margin pressures, including an estimated ~$320 million EBIT headwind by FY26 from increased tariffs and the removal of the de minimis trade exemption. Goldman Sachs quantifies these pressures as a ~170bps headwind from the de minimis change alone, plus additional impacts from tariffs (~50bps), promotional activity (~50bps), and SG&A deleverage (~80-90bps). While the company recently beat Q2 EPS forecasts ($3.10 vs. $2.87), a slight revenue miss ($2.53B vs. $2.54B) and downgrades from William Blair and Stifel underscore concerns about US sales recovery and macroeconomic challenges. Lululemon's strategy to accelerate product newness is currently viewed as insufficient to offset slowing sales momentum, resulting in increased markdown pressure. Despite these challenges and a 46% year-to-date stock decline, the company maintains strong underlying fundamentals, including a 59.1% gross profit margin and a low P/E ratio of 13.9, creating a classic conflict between current valuation and a deteriorating forward outlook.

Key Decisions for Investors

• Investors should closely monitor Lululemon's ability to manage the significant and quantifiable margin pressures, particularly the projected ~$320 million EBIT headwind from tariffs and the de minimis exemption change.
• The key metric to watch for a potential turnaround is sequential acceleration in full-priced sales, as current strategies to refresh product lines have not yet been sufficient to reverse slowing comparable sales momentum.
• Despite the stock's 46% year-to-date decline and a low P/E of 13.9, the consensus of downward earnings revisions and deteriorating forward guidance suggests significant near-term risk, positioning the stock as a potential value trap.
• Consider the wide analyst target range of $150 to $500 as an indicator of high uncertainty; performance will likely hinge on a tangible recovery in the U.S. market and stabilization in China.